Related Experiment Video
Updated: Feb 10, 2026
08:42
Transplantation of Whole Kidney Marrow in Adult Zebrafish
Published on: February 25, 2007
14.4K
Haploidentical stem cell transplantation-bone marrow vs peripheral blood.
1Anadolu Health Center, Department of Hematological Oncology and Bone Marrow Transplantation, 41400, Gebze, Kocaeli, Turkey.
Summary
Hematopoietic stem cell transplantation using either bone marrow or peripheral blood stem cells is safe for haploidentical transplants. Both sources offer good outcomes, but further research is needed to determine the optimal choice.
Area of Science:
- Hematology
- Transplantation immunology
Background:
- Hematopoietic stem cells (HSCs) are crucial for reconstituting the immune system after myeloablative therapy.
- HSCs can be sourced from bone marrow (BM), peripheral blood (PBSC), or umbilical cord blood.
- Peripheral blood stem cell transplantation (PBSCT) has gained popularity due to faster engraftment and logistical advantages.
Purpose of the Study:
- To compare the suitability of bone marrow (BM) versus peripheral blood stem cells (PBSC) as graft sources for haploidentical stem cell transplantation.
- To evaluate outcomes, including graft-versus-host disease (GVHD) and graft failure, associated with each stem cell source in the haploidentical setting.
Main Methods:
- Review of existing literature comparing outcomes of haploidentical stem cell transplantation using BM versus PBSC.
- Analysis of data regarding engraftment, GVHD incidence, and graft failure rates for both sources.
Main Results:
- Both bone marrow (BM) and peripheral blood stem cells (PBSC) can be safely utilized as allograft sources in haploidentical transplantation.
- Acceptable rates of graft-versus-host disease (GVHD) and graft failure were observed with both BM and PBSC sources.
- Peripheral blood stem cell transplantation (PBSCT) offers benefits in terms of faster engraftment and practicality.
Conclusions:
- Bone marrow (BM) and peripheral blood stem cells (PBSC) are both viable and safe options for haploidentical stem cell transplantation.
- Further prospective randomized studies are required to definitively ascertain the superiority of either peripheral blood (PB) or bone marrow (BM) in haploidentical transplantation settings.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
1.3K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.3K
01:29Blood and Nerve Supply to the Bones
13.9K
Bones are dynamic organs that require a rich supply of oxygen and nutrients. Around 5% to 10% of the cardiac output supplies blood to the bones. A typical long bone has three main sources: the nutrient artery, the metaphyseal and epiphyseal arteries, and the periosteal arteries.
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...
13.9K
01:13Induced Pluripotent Stem Cells
28.1K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
00:58Embryonic Stem Cells
32.6K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.6K
00:57Embryonic Stem Cells
5.2K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.2K
01:33Adult Stem Cells
33.9K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K